investordatabase.org

OMX Ventures, LLC

omx.vc Direct investor

OMX Ventures is a venture capital firm that invests in biotechnology companies, focusing on therapeutics, bio-tools, diagnostics, and synthetic biology. It operates in the US and Europe.

OMX Ventures, LLC is a venture capital firm headquartered in United States. It invests directly in companies, from seed to Series B, in biotech, therapeutics, BioTools & Diagnostics and synthetic Biology.

“Using a technology-first approach, OMX takes groundbreaking discoveries and grows them into scalable biotech companies on both sides of the Atlantic.”

— OMX Ventures, LLC, own website
Layer
Direct investor
Type
Venture capital
Stage
Seed – Series B
Headquarters
United States
Invests in
US, Europe
Sectors
Biotech, Therapeutics, BioTools & Diagnostics, Synthetic Biology

Team, as OMX Ventures, LLC publishes it

  • Dan Fero Managing Director
  • Craig Asher Managing Director
  • Nick Haft Managing Director
  • Swetha Murali Vice President
  • Natasha Azar Vice President Investor Relations
  • Tim Richardson Venture Partner
  • John Nawrocki Chief Financial Officer
  • Paul Conley Venture Partner
  • Fred Sweeney Venture Partner

Names and roles exactly as listed on omx.vc. Nothing else about these people is recorded.

Co-invests most often with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 38 co-investors found.

and 28 more — the graph.

Where this comes from

Every fact above was read from a page OMX Ventures, LLC publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 3408 · added 2026-09-03 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under